Physician profile
Michael Strickland
NPI 1528033537
$847.40
in general payments reported to CMS, 2019-2025
29 companies · $54.28 in 2025
The $54.28 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $11.53 · 2021: $64.55 · 2022: $151 · 2023: $57.99 · 2024: $102 · 2025: $54.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $127.43 | 2019-2020 | |
| Boston Scientific Corporation | $105.31 | 2019-2022 | |
| Astellas Pharma US INC | $54.91 | 2019-2023 | Myrbetriq |
| Coloplast Corp | $40.84 | 2022-2024 | |
| Olympus America INC. | $40.60 | 2021-2024 | Itind System |
| Urovant Sciences INC | $36.22 | 2021-2022 | |
| Allergan, INC. | $32.04 | 2019 | |
| Blue Earth Diagnostics | $31.78 | 2019 | |
| Pfizer INC. | $28.59 | 2019 | |
| Abbvie INC. | $28.10 | 2019 | |
| Convatec INC. | $23.52 | 2025 | |
| Nevro Corp. | $22.55 | 2024 | Senza |
| Procept Biorobotics Corporation | $21.48 | 2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $19.08 | 2019 | |
| Ethicon US, LLC | $18.95 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Civco Medical Instruments | $17.94 | 2024 | |
| Neotract INC. | $17.76 | 2019 | |
| Dendreon Pharmaceuticals LLC | $17.17 | 2019 | |
| 180 Medical, INC. | $17.02 | 2019 | |
| Urogen Pharma, INC. | $16.71 | 2025 | |
| Travere Therapeutics, INC. | $16.44 | 2019 | |
| Antares Pharma, INC. | $16.28 | 2019 | |
| Myovant Sciences INC. | $15.44 | 2022 | |
| Laborie Medical Technologies Corp. | $14.05 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $14.02 | 2023 | |
| Myriad Genetic Laboratories, INC. | $13.69 | 2021 | |
| Axonics, INC. | $13.65 | 2022 | |
| Tolmar, INC. | $13.16 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.